Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mutations could allow H7N9 to spread among humans
H7N9 usually infects birds but has spread to at least 779 humans in outbreaks linked to poultry markets.
Monitoring mutations ‘could help to prevent pandemic’

Several genetic mutations could allow avian influenza H7N9 to spread from person to person, a team of international scientists has discovered.

H7N9 usually infects birds but has spread to at least 779 humans in outbreaks linked to poultry markets. While the virus cannot spread sustainably from person to person, scientists fear it could mutate into a form that can.

Led by James Paulson from The Scripps Research Institute (TSRI), researchers analysed mutations that could occur in the H7N9 genome, focusing on a gene that codes for the H7 hemagglutanin, a protein found on the surface of flu viruses that allows them to latch onto host cells.

Flu strains that circulate in avian viruses have different subtypes of hemagglutanin, called H1-H16, but so far only H1-H3 have been found in human flu viruses. H7N9 has specificity for receptors on bird cells, but not receptors on human cells, but a transition to human specificity could allow it to spread among humans.

Researchers used molecular modelling and knowledge of the hemagglutanin’s structure to pinpoint mutations that would cause a switch to human specificity. They produced the hemagglutanin with different combinations of the mutations in an experimental cell line, then harvested the mutant hemagglutanin protein from the cells.

Several forms with mutations in three amino acids bound far more strongly to human receptors, according to findings published in the journal PLOS Pathogens. In other words, they had switched specificity from bird to human. The triple-mutant H7 hemagglutanins also latched onto cells in samples of human trachea tissue.

Scientists were limited in their ability to test these effects in animals as safety regulations prohibit introducing the mutations to actual H7N9 viruses. However, researchers believe that observing the development of these mutations in humans with H7N9 could help to ensure a timely response to prevent a pandemic.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.